Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos Genomics to Provide Proctor & Gamble with Drug Targets

NEW YORK, June 11 - Galapagos Genomics has signed on to provide Procter & Gamble Pharmaceuticals with protein drug targets related to osteoporosis, the Mechelen, Belgium, company said today.

 

Under the agreement, Galapagos will provide Proctor & Gamble with protein targets that impact bone formation. Proctor & Gamble will validate the targets and may initiate development of osteoporosis drug candidates based on these targets.

 

Galapagos is to receive option fees, milestone payments, and royalties on sales of any products developed from these targets, the company said, but did not disclose further financial terms of the deal.

 

Galapagos has discovered these targets using PhenoSelect, its gene expression platform which uses arrayed adenoviruses containing human genes to identify and validate targets.

 

This agreement expands on a a previous deal in which Proctor & Gamble agreed to use PhenoSelect to discover targets internally.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.